The private demand for an AIDS vaccine in Thailand.
A contingent valuation survey of Thai adults revealed that private demand for a hypothetical AIDS vaccine that is safe, has no side effects, and lasts 10 years, rises with income, the lifetime risk of HIV infection and vaccine efficacy, and declines with vaccine price and respondent's age. Demand for both high (95%) and low (50%) efficacy AIDS vaccines is substantial. Nearly 80% of adults would agree to be vaccinated with a free vaccine. Government will have an important role to ensure that those at highest risk of HIV infection with low incomes have access to the vaccine and to reinforce other safe preventive behavior to prevent reductions in condom use.
Suraratdecha
Chutima
C
International Health Policy Program, Ministry of Public Health, Tiwanon Rd., Nonthaburi, Thailand. csuraratdecha@iavi.org
Ainsworth
Martha
M
Tangcharoensathien
Viroj
V
Whittington
Dale
D
D016915:AIDS Vaccines / Q000191:economics / Q000592:standards / Q000600:supply & distribution; D000328:Adult; D001294:Attitude to Health; D005260:Female; D015658:HIV Infections / Q000453:epidemiology / Q000517:prevention & control*; D019538:Health Care Surveys; D006297:Health Services Accessibility; D006301:Health Services Needs and Demand / Q000706:statistics & numerical data*; D006801:Humans; D017589:Immunization Programs; D008297:Male; D008875:Middle Aged; D018570:Risk Assessment; D012959:Socioeconomic Factors; D011795:Surveys and Questionnaires; D013785:Thailand / Q000453:epidemiology
D016915:AIDS Vaccines